{
    "xml": "<topic id=\"PHP81568\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/fungizone\" basename=\"fungizone\" title=\"Fungizone\">\n<title>Fungizone<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP83510\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/clinical-medicinal-product-information/fungizone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Systemic fungal infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Test dose 1&#8239;mg, to be given over 20&#8211;30 minutes, then 250&#8239;micrograms/kg daily, gradually increased over 2&#8211;4 days, increased if tolerated to 1&#8239;mg/kg daily, max. (severe infection) 1.5&#8239;mg/kg daily or on alternate days. Prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250&#8239;micrograms/kg daily and increase gradually.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP83524\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/clinical-medicinal-product-information/fungizone\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>\n<b>Amphotericin (as sodium deoxycholate complex)</b>\n</p>\n<p>For <i>intravenous infusion</i> (<i>Fungizone</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5%. Reconstitute each vial with 10&#8239;mL water of injections and shake immediately to produce a 5&#8239;mg/mL colloidal solution; dilute further in infusion fluid to a concentration of 100&#8239;micrograms/mL; pH of the glucose must not be below 4.2 (check each container&#8212;consult product literature for details of the buffer); infuse over 2&#8211;4 hours, or longer if not tolerated (initial test dose of 1&#8239;mg over 20&#8211;30 minutes); begin infusion immediately after dilution; protect from light; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or use separate line; an in-line filter (pore size no less than 1&#8239;micron) may be used.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP81568",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/fungizone",
    "basename": "fungizone",
    "title": "Fungizone",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Systemic fungal infections",
                        "html": "Systemic fungal infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Test dose 1 mg, to be given over 20&#8211;30 minutes, then 250 micrograms/kg daily, gradually increased over 2&#8211;4 days, increased if tolerated to 1 mg/kg daily, max. (severe infection) 1.5 mg/kg daily or on alternate days. Prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250 micrograms/kg daily and increase gradually.",
                        "html": "<p>Test dose 1&#8239;mg, to be given over 20&#8211;30 minutes, then 250&#8239;micrograms/kg daily, gradually increased over 2&#8211;4 days, increased if tolerated to 1&#8239;mg/kg daily, max. (severe infection) 1.5&#8239;mg/kg daily or on alternate days. Prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250&#8239;micrograms/kg daily and increase gradually.</p>"
                    }
                ]
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Amphotericin (as sodium deoxycholate complex)\n\nFor intravenous infusion (Fungizone ), give intermittently in Glucose 5%. Reconstitute each vial with 10 mL water of injections and shake immediately to produce a 5 mg/mL colloidal solution; dilute further in infusion fluid to a concentration of 100 micrograms/mL; pH of the glucose must not be below 4.2 (check each container&#8212;consult product literature for details of the buffer); infuse over 2&#8211;4 hours, or longer if not tolerated (initial test dose of 1 mg over 20&#8211;30 minutes); begin infusion immediately after dilution; protect from light; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or use separate line; an in-line filter (pore size no less than 1 micron) may be used.",
                "html": "<p>\n<b>Amphotericin (as sodium deoxycholate complex)</b>\n</p><p>For <i>intravenous infusion</i> (<i>Fungizone</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5%. Reconstitute each vial with 10&#8239;mL water of injections and shake immediately to produce a 5&#8239;mg/mL colloidal solution; dilute further in infusion fluid to a concentration of 100&#8239;micrograms/mL; pH of the glucose must not be below 4.2 (check each container&#8212;consult product literature for details of the buffer); infuse over 2&#8211;4 hours, or longer if not tolerated (initial test dose of 1&#8239;mg over 20&#8211;30 minutes); begin infusion immediately after dilution; protect from light; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or use separate line; an in-line filter (pore size no less than 1&#8239;micron) may be used.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}